Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: Canada Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20057
20062
20071
20083
20091
20101
20112
20121
20135
20141
20152
20171
20181
20191
20201
20211
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated6
Recruiting4
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Population Health Research Institute3
AstraZeneca2
Boehringer Ingelheim2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
Montreal Heart Institute2
Ottawa Heart Institute Research Corporation2
Pfizer2
Sanofi2
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction41
Stroke17
Cardiovascular Diseases14
Acute Coronary Syndrome7
Coronary Artery Disease7
Angina, Unstable5
Heart Diseases5
ST Elevation Myocardial Infarction5
Atherosclerosis3
Coronary Disease3

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.